Co-Authors
This is a "connection" page, showing publications co-authored by Leo Hanke and Gerald McInerney.
Connection Strength
1.597
-
An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction. Nat Commun. 2020 09 04; 11(1):4420.
Score: 0.901
-
Picomolar SARS-CoV-2 Neutralization Using Multi-Arm PEG Nanobody Constructs. Biomolecules. 2020 12 11; 10(12).
Score: 0.229
-
Systematic evaluation of SARS-CoV-2 antigens enables a highly specific and sensitive multiplex serological COVID-19 assay. Clin Transl Immunology. 2021; 10(7):e1312.
Score: 0.060
-
Multianalyte serology in home-sampled blood enables an unbiased assessment of the immune response against SARS-CoV-2. Nat Commun. 2021 06 17; 12(1):3695.
Score: 0.059
-
Seropositivity in blood donors and pregnant women during the first year of SARS-CoV-2 transmission in Stockholm, Sweden. J Intern Med. 2021 09; 290(3):666-676.
Score: 0.059
-
SARS-CoV-2 protein subunit vaccination of mice and rhesus macaques elicits potent and durable neutralizing antibody responses. Cell Rep Med. 2021 04 20; 2(4):100252.
Score: 0.059
-
DNA-launched RNA replicon vaccines induce potent anti-SARS-CoV-2 immune responses in mice. Sci Rep. 2021 02 04; 11(1):3125.
Score: 0.058
-
Adjuvanted SARS-CoV-2 spike protein elicits neutralizing antibodies and CD4 T cell responses after a single immunization in mice. EBioMedicine. 2021 Jan; 63:103197.
Score: 0.058
-
Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2. Nat Commun. 2020 11 04; 11(1):5588.
Score: 0.057
-
SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden. Nat Commun. 2020 10 08; 11(1):5064.
Score: 0.057